-+ 0.00%
-+ 0.00%
-+ 0.00%

ESPERION THERAPEUTICS: PATENT LITIGATION AGAINST REMAINING DEFENDANTS; MSN PHARMACEUTICALS & SANDOZ CONTINUES

Reuters·11/10/2026 13:48:14